The respiratory, circulatory, and narcotic antagonistic effects of nalorphine, levallorphan, and naloxone in anaesthetized subjects.
D000293:Adolescent; D000328:Adult; D000769:Anesthesia, Inhalation; D001794:Blood Pressure / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007040:Hypoventilation / Q000139:chemically induced; D007977:Levallorphan / Q000009:adverse effects*; D008875:Middle Aged; D009269:Nalorphine / Q000009:adverse effects*; D009292:Narcotic Antagonists / Q000009:adverse effects* / Q000494:pharmacology; D009609:Nitrous Oxide; D010111:Oxymorphone / Q000037:antagonists & inhibitors; D011674:Pulse / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012131:Respiratory Insufficiency / Q000139:chemically induced*; D013874:Thiopental
D009292:Narcotic Antagonists; D007977:Levallorphan; D010111:Oxymorphone; D013874:Thiopental; D009609:Nitrous Oxide; D009269:Nalorphine